TY - JOUR
T1 - Predictors and outcomes of limited resection for early-stage non-small cell lung cancer
AU - Billmeier, Sarah E.
AU - Ayanian, John Z.
AU - Zaslavsky, Alan M.
AU - Nerenz, David R.
AU - Jaklitsch, Michael T.
AU - Rogers, Selwyn O.
PY - 2011/11/2
Y1 - 2011/11/2
N2 - Background Lobectomy is considered the standard treatment for early-stage non-small cell lung cancer (NSCLC); however, more limited resections are commonly performed. We examined patient and surgeon factors associated with limited resection and compared postoperative and long-term outcomes between sublobar and lobar resections. Methods A population-and health system-based sample of patients newly diagnosed with stage I or II NSCLC between 2003 and 2005 in five geographically defined regions, five integrated health-care delivery systems, and 15 Veterans Affairs hospitals was observed for a median of 55 months, through May 31, 2010. Predictors of limited resection and postoperative outcomes were compared using unadjusted and propensity score-weighted analyses. All P values are from two-sided tests. Results One hundred fifty-five (23%) patients underwent limited resection and 524 (77%) underwent lobectomy. In adjusted analyses of patient-specific factors, smaller tumor size (P =. 004), coverage by Medicare or Medicaid, no insurance or unknown insurance (P =. 02), more severe lung disease (P <. 001), and a history of stroke (P =. 049) were associated with receipt of limited resection. In adjusted analyses of surgeon characteristics, thoracic surgery specialty (P =. 02), non-fee-for-service compensation (P =. 008), and National Cancer Institute cancer center designation (P =. 006) were associated with higher odds of limited resection. Unadjusted 30-day mortality was higher with limited resection than with lobectomy (7.1% vs 1.9%, difference = 5.2%, 95% confidence interval [CI] = 1.5% to 10.8%, P =. 003), and the adjusted difference was not statistically significant (6.5% vs 2.9%, difference = 3.6%, 95% CI =-.1% to 9.2%, P =. 09). Postoperative complications did not differ by type of surgery (all P >. 05). Over the course of the study, a non-statistically significant trend toward improved long-term survival was evident for lobectomy, compared with limited resection, in adjusted analyses (hazard ratio of death = 1.35 for limited resection, 95% CI = 0.99 to 1.84, P =. 05). Conclusions Evidence is statistically inconclusive but suggestive that lobectomy, compared with limited resection, is associated with increased long-term survival for early-stage lung cancer. Clinical, socioeconomic, and surgeon factors appear to be associated with the choice of surgical resection.
AB - Background Lobectomy is considered the standard treatment for early-stage non-small cell lung cancer (NSCLC); however, more limited resections are commonly performed. We examined patient and surgeon factors associated with limited resection and compared postoperative and long-term outcomes between sublobar and lobar resections. Methods A population-and health system-based sample of patients newly diagnosed with stage I or II NSCLC between 2003 and 2005 in five geographically defined regions, five integrated health-care delivery systems, and 15 Veterans Affairs hospitals was observed for a median of 55 months, through May 31, 2010. Predictors of limited resection and postoperative outcomes were compared using unadjusted and propensity score-weighted analyses. All P values are from two-sided tests. Results One hundred fifty-five (23%) patients underwent limited resection and 524 (77%) underwent lobectomy. In adjusted analyses of patient-specific factors, smaller tumor size (P =. 004), coverage by Medicare or Medicaid, no insurance or unknown insurance (P =. 02), more severe lung disease (P <. 001), and a history of stroke (P =. 049) were associated with receipt of limited resection. In adjusted analyses of surgeon characteristics, thoracic surgery specialty (P =. 02), non-fee-for-service compensation (P =. 008), and National Cancer Institute cancer center designation (P =. 006) were associated with higher odds of limited resection. Unadjusted 30-day mortality was higher with limited resection than with lobectomy (7.1% vs 1.9%, difference = 5.2%, 95% confidence interval [CI] = 1.5% to 10.8%, P =. 003), and the adjusted difference was not statistically significant (6.5% vs 2.9%, difference = 3.6%, 95% CI =-.1% to 9.2%, P =. 09). Postoperative complications did not differ by type of surgery (all P >. 05). Over the course of the study, a non-statistically significant trend toward improved long-term survival was evident for lobectomy, compared with limited resection, in adjusted analyses (hazard ratio of death = 1.35 for limited resection, 95% CI = 0.99 to 1.84, P =. 05). Conclusions Evidence is statistically inconclusive but suggestive that lobectomy, compared with limited resection, is associated with increased long-term survival for early-stage lung cancer. Clinical, socioeconomic, and surgeon factors appear to be associated with the choice of surgical resection.
UR - http://www.scopus.com/inward/record.url?scp=80655125047&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80655125047&partnerID=8YFLogxK
U2 - 10.1093/jnci/djr387
DO - 10.1093/jnci/djr387
M3 - Article
C2 - 21960708
AN - SCOPUS:80655125047
SN - 0027-8874
VL - 103
SP - 1621
EP - 1629
JO - Journal of the National Cancer Institute
JF - Journal of the National Cancer Institute
IS - 21
ER -